What can the placebo effect actually change?
The placebo effect is not just imagination. It is a real mind-body response that can reduce pain, anxiety, and fatigue by activating the body's own opioid, endocannabinoid, and dopamine systems [2]. In pain especially, placebo analgesia—pain relief from an inert treatment—is well documented and can be meaningful for patients. But the same review stresses that placebos should only ever be a complementary or adjunctive therapy; they must never replace specific treatments for clearly identifiable organic pathologies [2].
The effect can also show up in objective measurements, not just subjective feelings. In a pooled analysis of seven early-phase trials for nonalcoholic steatohepatitis (NASH, a fatty liver disease), 20% of participants receiving placebo had at least a 30% relative reduction in liver fat after 12 weeks, and 28% did after 24 weeks [1]. On average, liver fat dropped by about 2.3 units—a median relative reduction of 13%—after 24 weeks of placebo [1]. That is a measurable biological change, but it is modest and variable, not a cure.
Why does the placebo effect have a ceiling?
The placebo effect works through expectation, conditioned reflexes, and social learning—basically, the brain mobilizing the body's internal pharmacy [2]. That mechanism can influence symptoms and some physiological processes, but it cannot remove a tumor, clear an infection, or repair a damaged organ. This is why the effect is best understood as symptom relief and modulation rather than disease reversal. The NASH analysis illustrates the point: even when placebo produced a statistically significant drop in liver fat, most participants did not reach the 30% reduction threshold, and the average change was small [1].
An older paper framed the limit as a practical one: until a limit is specified, any failure of placebo to produce effects is assumed to be a temporary practical limitation, not an intrinsic property of placebo itself [3]. In other words, we may not yet know the absolute ceiling, but the evidence so far shows the effect is constrained by the condition and the outcome being measured.
When is the placebo effect strongest—and when does it fade?
Placebo effects tend to be most reliable for subjective symptoms such as pain, anxiety, and fatigue, where expectation and belief can directly shape experience [2]. They are less reliable for hard disease outcomes. In the NASH trials, the proportion of patients achieving a 30% liver fat reduction varied by treatment duration—20% at 12 weeks, 9% at 16 weeks, and 28% at 24 weeks—showing that the effect is not a fixed quantity but fluctuates with time and context [1].
The effect also depends on how placebo is delivered. Traditional deceptive placebos, where patients are not told they are receiving an inert treatment, are being replaced by open-label placebos, which are given transparently and still produce meaningful clinical benefits [2]. This suggests that the ritual and relationship of treatment matter, but it also means the effect is sensitive to expectation and communication—factors that can be strengthened or weakened. The limits of placebo and nocebo effects are still an active question, and researchers continue to probe exactly where the boundaries lie [4][5].
Sources used in this answer
MRI Quantification of Placebo Effect in Nonalcoholic Steatohepatitis Clinical Trials
In 187 participants with nonalcoholic steatohepatitis, placebo treatment produced a clinically relevant decrease in liver fat (average 2.3 units, median 13% relative reduction after 24 weeks), with 20–28% of participants achieving at least a 30% relative reduction depending on trial duration.
The Placebo Effect in Pain: Mechanisms, Applications, and Ethical Considerations
The placebo effect can reduce pain, anxiety, and fatigue through endogenous opioid, endocannabinoid, and dopaminergic systems, but placebos should be used only as complementary therapy and never replace specific treatment for organic disease.
The placebo effect and the cognitive-behavioral revolution
Any failure of placebo to produce effects should be considered a temporary practical limitation rather than an intrinsic property of placebo until a specific limit is established.
You may (not always) experience what you expect: in search for the limits of the placebo and nocebo effect
The paper examines the limits of the placebo and nocebo effects, focusing on the boundaries of these phenomena.
The placebo effect: illness and interpersonal healing
The paper investigates the scope and limits of the placebo effect, including the hypothesis that it operates predominantly through interpersonal healing.